![]() |
![]() ![]() |
Dabrafenib (GSK2118436) |
Create: 09/23/2019 |
Expired Date: | never |
Category: | Chemical |
Message: | Dabrafenib (GSK2118436) is a mutant BRAFV600 specific inhibitor with IC50 of 0.8 nM, with 4- and 6-fold less potency against B-Raf(wt) and c-Raf, respectively.https://www.bocsci.com/dabrafenib-gsk2118436-cas-1195765-45-7-item-454193.html |
![]() | |
City: | New York[US]
![]() |
Location: |
|
Sep 23 2019 | ![]() | Y-27632 2HCl | 262 |
Sep 23 2019 | ![]() | BMS-911543 | 277 |
Sep 23 2019 | ![]() | JQ-1 cas 1268524-70-4 | 266 |
Sep 23 2019 | ![]() | Alectinib | 261 |
Sep 23 2019 | ![]() | Tubastatin A | 270 |
Sep 23 2019 | ![]() | FLLL32 | 269 |
Sep 23 2019 | ![]() | Thiazovivin | 271 |
Sep 23 2019 | ![]() | Alpelisib | 272 |
Sep 23 2019 | ![]() | Ribociclib | 250 |
Sep 23 2019 | ![]() | Midostaurin | 250 |
Copyright © toextrade Inc. All rights reserved. Contact us |